# Validation of Dyskinesia Rating Scales

> **NCT01071395** · PHASE4 · COMPLETED · sponsor: **Rush University Medical Center** · enrollment: 68 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Amantadine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01071395
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-04
- **Final completion:** 2013-06
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2022-12-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071395, "Validation of Dyskinesia Rating Scales". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01071395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*